FDA Inspection 1233237 — Rocky Mountain Tissue Bank
The FDA completed an inspection of Rocky Mountain Tissue Bank on Mar 4, 2024 in Aurora, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 4, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Aurora, CO (United States)